BioSpace News Archive

Business

World-Renown Spine Surgeon’s New Book Reveals How to Eliminate Back Pain Without Opioids

Written by Thomas J. Kleeman, M.D., Release Yourself from Back Pain Without Opioids is based on 30 years of research and details seven drug-free techniques for treating low back pain

October 31, 2019
·
2 min read
Policy

Cytotron® Granted ‘Breakthrough Device Designation’ by U.S. FDA for Treatment of Breast, Liver, and Pancreatic Cancers

The Center for Devices and Radiological Health of the U.S. Food and Drug Administration granted Shreis Scalene Sciences, in Gaithersburg, MD, ‘Breakthrough Device Designation’ for the CYTOTRON® - a CE marked, whole-body therapeutic medical device.

October 31, 2019
·
3 min read
Genetown

2019 Research Grant Recipients Announced by the VHL Alliance

The VHL Alliance (VHLA) today announced the 2019 recipients of the VHLA Competitive Research Grant Program.

October 31, 2019
·
3 min read
Drug Development

RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis

Positive top-line study results show that both doses of RINVOQ™ (upadacitinib; 15 mg and 30 mg, once daily) met the primary endpoint of ACR20 response in adult patients with active psoriatic arthritis who had an inadequate response to other bDMARDs at week 12 versus placebo

October 31, 2019
·
15 min read
Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)

Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of PrTeva-Fingolimod 0.5 mg capsules, a Health Canada approved, bioequivalent generic version of PrGilenya® in Canada.

October 31, 2019
·
6 min read
Business

Parexel Expands Collaboration with SCRS Through Leadership of Patient-Focused Initiatives to Drive Engagement and Diversity in Clinical TrialsAs a Site Engagement Partner, Parexel will help to enrich connections between sit

Parexel announced the expansion of its collaboration with the Society for Clinical Research Sites, the first and only global organization fully dedicated to representing the interests of clinical research sites.

October 31, 2019
·
3 min read
BioCapital

Stryker receives FDA clearance for SAHARA® Lateral 3D Expandable Interbody System

Stryker announced today the U.S. Food and Drug Administration (FDA) 510(k) clearance of its SAHARA Lateral 3D Expandable Interbody System featuring Lamellar 3D Titanium Technology, which will be on display at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum this week in Las Vegas, NV.

October 31, 2019
·
4 min read
BioCapital

Oncology Care Model Poster Presented by AMCP Foundation and Genentech Intern

AMCP Foundation recently completed another successful summer internship program organized by the Foundation and supported by Genentech, Inc.

October 31, 2019
·
1 min read
Biotech Bay

Myovant Sciences Enters Landmark Agreement with Sumitomo Dainippon Pharma to Secure Major Financial Backing and Safeguards for Minority Shareholders

Sumitomo Dainippon Pharma to provide Myovant Sciences with a $350 million, low-interest, five-year term loan facility, with no repayments due until the end of the term

October 31, 2019
·
8 min read
Lone Star Bio

Reduce Stockouts in Hospitals to Near Zero with One Network’s Supply Chain Business Network Technology

Platform enhancements bring greater efficiency and accuracy to patient-driven supply chain management

October 31, 2019
·
5 min read